Rowena Bull
Rowena Bull
Verified email at
Cited by
Cited by
Emergence of a new norovirus genotype II. 4 variant associated with global outbreaks of gastroenteritis
RA Bull, ETV Tu, CJ McIver, WD Rawlinson, PA White
Journal of clinical microbiology 44 (2), 327-333, 2006
Norovirus recombination
RA Bull, MM Tanaka, PA White
Journal of General Virology 88 (12), 3347-3359, 2007
Rapid evolution of pandemic noroviruses of the GII. 4 lineage
RA Bull, JS Eden, WD Rawlinson, PA White
PLoS pathogens 6 (3), e1000831, 2010
Norovirus recombination in ORF1/ORF2 overlap
RA Bull, GS Hansman, LE Clancy, MM Tanaka, WD Rawlinson, PA White
Emerging infectious diseases 11 (7), 1079, 2005
Evolution of the SARS‐CoV‐2 omicron variants BA. 1 to BA. 5: implications for immune escape and transmission
LB Shrestha, C Foster, W Rawlinson, N Tedla, RA Bull
Reviews in Medical Virology 32 (5), e2381, 2022
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection
RA Bull, F Luciani, K McElroy, S Gaudieri, ST Pham, A Chopra, ...
PLoS pathogens 7 (9), e1002243, 2011
Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII. 4 variants 2006a and 2006b
ETV Tu, RA Bull, GE Greening, J Hewitt, MJ Lyon, JA Marshall, CJ McIver, ...
Clinical infectious diseases 46 (3), 413-420, 2008
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
RA Bull, TN Adikari, JM Ferguson, JM Hammond, I Stevanovski, ...
Nature communications 11 (1), 6272, 2020
Mechanisms of GII. 4 norovirus evolution
RA Bull, PA White
Trends in microbiology 19 (5), 233-240, 2011
The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry
SK Narayana, KJ Helbig, EM McCartney, NS Eyre, RA Bull, A Eltahla, ...
Journal of Biological Chemistry 290 (43), 25946-25959, 2015
Norovirus excretion in an aged-care setting
ETV Tu, RA Bull, MJ Kim, CJ McIver, L Heron, WD Rawlinson, PA White
Journal of clinical microbiology 46 (6), 2119-2121, 2008
Inhibitors of the hepatitis C virus polymerase; mode of action and resistance
AA Eltahla, F Luciani, PA White, AR Lloyd, RA Bull
Viruses 7 (10), 5206-5224, 2015
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
J Grebely, ST Pham, GV Matthews, K Petoumenos, RA Bull, B Yeung, ...
Hepatology 55 (4), 1058-1069, 2012
Contribution of intra-and interhost dynamics to norovirus evolution
RA Bull, JS Eden, F Luciani, K McElroy, WD Rawlinson, PA White
Journal of virology 86 (6), 3219-3229, 2012
Frequent multiple hepatitis C virus infections among injection drug users in a prison setting
ST Pham, RA Bull, JM Bennett, WD Rawlinson, GJ Dore, AR Lloyd, ...
Hepatology 52 (5), 1564-1572, 2010
Norovirus GII. 4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008
JS Eden, RA Bull, E Tu, CJ McIver, MJ Lyon, JA Marshall, DW Smith, ...
Journal of Clinical Virology 49 (4), 265-271, 2010
Viral quasispecies assembly via maximal clique enumeration
A Töpfer, T Marschall, RA Bull, F Luciani, A Schönhuth, N Beerenwinkel
PLoS computational biology 10 (3), e1003515, 2014
Linking the T cell receptor to the single cell transcriptome in antigen‐specific human T cells
AA Eltahla, S Rizzetto, MR Pirozyan, BD Betz‐Stablein, V Venturi, ...
Immunology and cell biology 94 (6), 604-611, 2016
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
Z Wang, L Zhu, THO Nguyen, Y Wan, S Sant, SM Quiñones-Parra, ...
Nature communications 9 (1), 824, 2018
Next generation deep sequencing and vaccine design: today and tomorrow
F Luciani, RA Bull, AR Lloyd
Trends in biotechnology 30 (9), 443-452, 2012
The system can't perform the operation now. Try again later.
Articles 1–20